Easy Access and Express Report Delivery Service
Highlights The global Nocturia market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029. North American market for Nocturia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Asia-Pacific market for Nocturia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. The major global companies of Nocturia include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott and Teva, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue. The global market for Nocturia in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Desmopressin, which accounted for % of the global market of Nocturia in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia. The Nocturia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Nocturia by Type 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) 1.2.2 Desmopressin 1.2.3 Anticholinergic Drugs 1.2.4 Alpha Blockers 1.2.5 Diuretics 1.2.6 Others 2.3 Nocturia by Sale Channels 2.3.1 Market Value Comparison by Sale Channels (2018 VS 2022 VS 2029) 2.3.2 Hospital Pharmacies 2.3.3 Retail Pharmacies 2.3.4 Online Pharmacies 2.4 Assumptions and Limitations 3 Nocturia Breakdown Data by Type 3.1 Global Nocturia Historic Market Size by Type (2018-2023) 3.2 Global Nocturia Forecasted Market Size by Type (2023-2028) 4 Nocturia Breakdown Data by Sale Channels 4.1 Global Nocturia Historic Market Size by Sale Channels (2018-2023) 4.2 Global Nocturia Forecasted Market Size by Sale Channels (2018-2023) 5 Global Growth Trends 5.1 Global Nocturia Market Perspective (2018-2029) 5.2 Global Nocturia Growth Trends by Region 5.2.1 Global Nocturia Market Size by Region: 2018 VS 2022 VS 2029 5.2.2 Nocturia Historic Market Size by Region (2018-2023) 5.2.3 Nocturia Forecasted Market Size by Region (2024-2029) 5.3 Nocturia Market Dynamics 5.3.1 Nocturia Industry Trends 5.3.2 Nocturia Market Drivers 5.3.3 Nocturia Market Challenges 5.3.4 Nocturia Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Nocturia Players by Revenue 6.1.1 Global Top Nocturia Players by Revenue (2018-2023) 6.1.2 Global Nocturia Revenue Market Share by Players (2018-2023) 6.2 Global Nocturia Industry Players Ranking, 2021 VS 2022 VS 2023 6.3 Global Key Players of Nocturia Head office and Area Served 6.4 Global Nocturia Players, Product Type & Application 6.5 Global Nocturia Players, Date of Enter into This Industry 6.6 Global Nocturia Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Nocturia Market Size (2018-2029) 7.2 North America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 North America Nocturia Market Size by Country (2018-2023) 7.4 North America Nocturia Market Size by Country (2024-2029) 7.5 United States 7.6 Canada 8 Europe 8.1 Europe Nocturia Market Size (2018-2029) 8.2 Europe Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 8.3 Europe Nocturia Market Size by Country (2018-2023) 8.4 Europe Nocturia Market Size by Country (2024-2029) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Nocturia Market Size (2018-2029) 9.2 Asia-Pacific Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Asia-Pacific Nocturia Market Size by Country (2018-2023) 9.4 Asia-Pacific Nocturia Market Size by Country (2024-2029) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 10 Latin America 10.1 Latin America Nocturia Market Size (2018-2029) 10.2 Latin America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Latin America Nocturia Market Size by Country (2018-2023) 10.4 Latin America Nocturia Market Size by Country (2024-2029) 9.4 Mexico 9.5 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Nocturia Market Size (2018-2029) 11.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 11.3 Middle East & Africa Nocturia Market Size by Country (2018-2023) 11.4 Middle East & Africa Nocturia Market Size by Country (2024-2029) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 12 Players Profiled 11.1 Astellas Pharma 11.1.1 Astellas Pharma Company Detail 11.1.2 Astellas Pharma Business Overview 11.1.3 Astellas Pharma Nocturia Introduction 11.1.4 Astellas Pharma Revenue in Nocturia Business (2017-2022) 11.1.5 Astellas Pharma Recent Development 11.2 Allergan 11.2.1 Allergan Company Detail 11.2.2 Allergan Business Overview 11.2.3 Allergan Nocturia Introduction 11.2.4 Allergan Revenue in Nocturia Business (2017-2022) 11.2.5 Allergan Recent Development 11.3 Ferring Pharmaceuticals 11.3.1 Ferring Pharmaceuticals Company Detail 11.3.2 Ferring Pharmaceuticals Business Overview 11.3.3 Ferring Pharmaceuticals Nocturia Introduction 11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2017-2022) 11.3.5 Ferring Pharmaceuticals Recent Development 11.4 Eli Lilly 11.4.1 Eli Lilly Company Detail 11.4.2 Eli Lilly Business Overview 11.4.3 Eli Lilly Nocturia Introduction 11.4.4 Eli Lilly Revenue in Nocturia Business (2017-2022) 11.4.5 Eli Lilly Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Detail 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Nocturia Introduction 11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2017-2022) 11.5.5 GlaxoSmithKline Recent Development 11.6 Sanofi 11.6.1 Sanofi Company Detail 11.6.2 Sanofi Business Overview 11.6.3 Sanofi Nocturia Introduction 11.6.4 Sanofi Revenue in Nocturia Business (2017-2022) 11.6.5 Sanofi Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Detail 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Nocturia Introduction 11.7.4 Pfizer Revenue in Nocturia Business (2017-2022) 11.7.5 Pfizer Recent Development 11.8 Abbott 11.8.1 Abbott Company Detail 11.8.2 Abbott Business Overview 11.8.3 Abbott Nocturia Introduction 11.8.4 Abbott Revenue in Nocturia Business (2017-2022) 11.8.5 Abbott Recent Development 11.9 Teva 11.9.1 Teva Company Detail 11.9.2 Teva Business Overview 11.9.3 Teva Nocturia Introduction 11.9.4 Teva Revenue in Nocturia Business (2017-2022) 11.9.5 Teva Recent Development 11.10 Mylan 11.10.1 Mylan Company Detail 11.10.2 Mylan Business Overview 11.10.3 Mylan Nocturia Introduction 11.10.4 Mylan Revenue in Nocturia Business (2017-2022) 11.10.5 Mylan Recent Development 11.11 Johnson & Johnson 11.11.1 Johnson & Johnson Company Detail 11.11.2 Johnson & Johnson Business Overview 11.11.3 Johnson & Johnson Nocturia Introduction 11.11.4 Johnson & Johnson Revenue in Nocturia Business (2017-2022) 11.11.5 Johnson & Johnson Recent Development 11.12 Hainan Zhonghe Pharmaceutical 11.12.1 Hainan Zhonghe Pharmaceutical Company Detail 11.12.2 Hainan Zhonghe Pharmaceutical Business Overview 11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction 11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2017-2022) 11.12.5 Hainan Zhonghe Pharmaceutical Recent Development 13 Report Conclusion 14 Disclaimer